Zydus Lifesciences has completed the acquisition of French orthopedic company Aptitude Orthopedie through its indirect wholly owned subsidiary Amplitude SAS, as disclosed in a regulatory filing under SEBI Listing Regulations.

Transaction Overview

Amplitude SAS acquired 100% share capital of Aptitude Orthopedie for €360,000 in cash consideration. The transaction was completed on April 30, 2026, with the company filing the disclosure on May 1, 2026, to BSE and NSE under Regulation 30 requirements.

Target Company Profile

Aptitude Orthopedie, incorporated in 2016, specializes in the distribution of medical equipment with a focus on orthopedic products. The company operates under an exclusive commercial agency agreement with Amplitude for French departments 14 and 50, excluding establishments shared with F.B.C MEDICAL.

The target entity has an authorized and paid-up share capital of €5,000, divided into 5,000 equity shares of €1 each.

Strategic Rationale

The acquisition aims to internalize commercial capabilities currently outsourced to third-party sales agents. By integrating Aptitude Orthopedie, Amplitude expects to eliminate ongoing commission and business-development fees, thereby reducing long-term selling and distribution costs. This strategic move strengthens Zydus Lifesciences' presence in the European orthopedic market through direct distribution capabilities.

The company confirmed that this acquisition does not constitute a related party transaction, with no promoter or group company interest in the target entity. No governmental or regulatory approvals were required for completing this transaction.

Source: Company/INE010B01027/def08fbd1814456a.pdf

Zydus life science has completed the acquisition of FBC Medical through its subsidiary Amplitude SAS, as disclosed in regulatory filings submitted to stock exchanges on May 1, 2026. The pharmaceutical company's indirect wholly owned subsidiary acquired complete ownership of the French medical equipment distributor for Euro 700,000.

Transaction Overview

Amplitude SAS purchased 100% share capital of FBC Medical, a simplified joint stock company registered in France. The acquisition was completed on April 30, 2026, through cash consideration.

Target Company Profile

FBC Medical operates as a specialized distributor of medical equipment with its registered office located at 8 Allée Jean-Marie Deguignet, 35850 GEVEZE, France. The company was incorporated in 2016 and maintains an exclusive sales agency agreement with Amplitude for French departments 35, 22, 29, and 56 across the entire territory of each department.

Financial Performance

The target entity demonstrates consistent financial performance with steady turnover based on audited financial statements:

FBC Medical maintains an authorized and paid-up share capital of Euro 5,000, divided into 5,000 equity shares of Euro 1 each.

Strategic Rationale

The acquisition serves to internalize commercial capabilities currently outsourced to third-party sales agents. By acquiring and integrating FBC Medical, Amplitude expects to eliminate ongoing commission and business-development fees, thereby reducing long-term selling and distribution costs.

Regulatory Compliance

Zydus Lifesciences disclosed that the acquisition does not fall within related party transactions, with no promoter, promoter group, or group companies having any interest in the target entity. The transaction required no governmental or regulatory approvals, facilitating smooth completion.

The acquisition details were disclosed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, ensuring full transparency with stakeholders and regulatory authorities.

Source: None/Company/INE010B01027/1173260afd29452f.pdf